Synthesis and crystal structure of 3,5-di(2-propenyl)-6-phenyl-1,3,5-triazine-2,4-dione and 2-dimethylamino-4-ethoxycarbonylmethoxy-6-phenyl-1,3,5-triazine

The title compound 3,5-di(2-propenyl)-6-phenyl-1,3,5-triazine-2,4-dione has been synthesized by the reaction of 6-phenyl-1,3,5-triazine-2,4-dione with allyl bromide. Its structure was determined by X-ray single crystal diffraction. The crystal belongs to orthorhombic, space group Pbca with the following crystallographic parameters: a = 16.282(4) Å, b = 8.888(2) Å, c = 19.281(5) Å, = 90°, = 90°, = 90°, = 0.088 mm^–1, V = 2790.1(13) ų, z = 8, Dx = 1.282 mg/m³, F(000) = 1136, T = 293(2) K, 2.11° 25.02°, the final R factor: R ₁ = 0.0430, wR₂ = 0.0981. The X-ray results demonstrate that the reaction of 6-phenyl-1,3,5-triazine-2,4-dione with allyl bromide in the presence of N,N-dimethylformamide and potassium carbonate yields the N-alkylated product. The title compound 2-dimethylamino-4-ethoxycarbonylmethoxy-6-phenyl-1,3,5-triazine has been synthesized by a new reaction, in which the solvent N,N-dimethylformamide involves. Its structure was determined by X-ray single crystal diffraction. The crystal belongs to triclinic, space group P-1 with the following crystallographic parameters: a = 7.977(2) Å, b = 10.394(3) Å, c = 10.837(3) Å, = 111.774(5)°, = 104.050(5)°, = 99.446(5)°, = 0.093 mm^–1, V = 776.6(4) ų, z = 2, Dx = 1.293 mg/m³, F(000) = 320, T = 293(2) K, 2.14° 25.03°, the final R factor: R ₁ = 0.0582, wR ₂ = 0.1399. The distance of N(4) C(2) (1.339 Å) is much shorter than the length of normal C N (1.47 Å) and very close to that of C-N (1.33 Å), which is indicative of the significant double bond character.     

Syntheses,crystal structures and properties of Cd(II) and Ag(I) complexes based on 2-p-methylphenyl-5-(2-pyridyl)-1,3,4-thiadiazole

Abstract

Complexes of [CdL₂(NO₃)₂]·1.5H₂O and [Ag₂(μ-L)₂(NO₃)₂] were synthesized by the reactions of 2-p-methylphenyl-5-(2-pyridyl)-1,3,4-thiadiazole (L) with Cd(NO₃)₂·4H₂O and AgNO₃, respectively. Their structures were determined by single crystal X-ray diffraction. The photophysical property and thermal stability were characterized by FT???IR, UV???Vis absorption, fluorescence, and thermogravimetric analysis (TGA). Both complexes belong to the triclinic system with space group p???1. The central metal of [CdL₂(NO₃)₂]·1.5H₂O has a distorted octahedral geometry [CdN₄O₂], while two central Ag(I) atoms of [Ag₂(μ-L)₂(NO₃)₂] exhibit distorted tetrahedral geometries [AgN₃O].     

X-ray crystal structure of 2-styrylpyridine

We have crystallized the 2-styrylpyridine from the condensation reaction between the 2-methylpyridine with benzaldehyde in the formation of the model compound 2-styrylpyridine. The X-ray structure and NMR are currently reported. The main features of the structure is that is shows a localization of the double bonds rather than a delocalization of π electrons in an aromatic fashion.     

Synthesis and X-ray structure of dichlorobis(8-(diphenylphosphinyl)quinoline)nickel(II)

Dichlorobis(8-(diphenylphosphinyl)quinoline)nickel(II) was formed in the reaction of 8-(diphenylphosphino)quinoline with nickel chloride in air. The title complex crystallized in P1 with the following cell dimensions: a = 8.5685(3) Å, b = 10.7736(2) Å, c = 13.4391(5) Å, and = 110.447(2)°, = 94.577(2)°; = 111.138(2)°, giving a volume of 1053.75(6) ų. The trans-dichlorobis(8-(diphenylphosphinyl)quinoline) nickel(II) adapts a central symmetric distorted octahedron. The structure is compared to other nickel(II) cation complexes, and possible reasons for the bonding states are discussed.     

4-(1,4-Dimethoxy-2-naphthyl)-4- hydroxycyclohexanone and its ethylene ketal

Intramolecular hydrogen bonding in the solid state is reported for the title compound and its ethylene ketal. The title compound crystallizes in the triclinic space group, with a = 9.590(3), b = 9.620(3), c = 9.844(2) Å, = 97.67(2), = 105.25(2), = 115.47(2), and Z=2. The ethylene ketal crystallizes in the monoclinic space group, P2₁/c, with a = 7.230(2), b = 22.639(3), c = 10.839(2) Å, = 101.47(2), and Z = 4. The intramolecular hydrogen bond length of 1.79 Å is the same for the ketone and ketal, but the O—H---O valence angle is 144° for the ketone and 165° for the ketal.     

X-ray crystal and molecular structure of [3,6-bis(2-pyridyl)pyridazine-N 1,N2]bis(triphenylphosphine) copper(I) hexafluorophosphate

[3,6-bis(2-pyridyl)pyridazine-N ¹,N²]bis(triphenylphosphine) copper(I) hexafluorophosphate crystallizes in space group $P\bar 1$ with cell dimensionaa=14.050(2),b=11.941(2),c=15.200(2) Å, α=71.28(1), β=67.02(1), and γ=84.78(2)^o. In the title compound, the mononuclear cation consists of a tetrahedral copper(I) center involving two nitrogen donors of the 3,6-bis(2-pyridyl)pyridazine (dppn) and two P atoms of the triphenylphosphine molecules. In the dppn ligand the two non-coordinating N atoms (one from pyridine and one from pyridazine) are mutallytrans.     

The structure of [Co(H-tptz)Cl3]·H2O (tptz=2,4,6-tri(2-pyridyl)-1,3,5-triazine) prepared by crystallization from the ionic liquid, N-butyl-N-methyl-pyrrolidinium bis(trifluoromethanesulfonyl)imide

The structure of tris-chloro[2,6-bis(2′-pyridyl)-4-(2′-pyridinium)-1,3,5-triazine]cobalt(II) monohydrate, [Co(C₁₈H₁₃N₆)Cl₃]·H₂O (C2/c (No. 15), a=7.783(11), b=22.42(3), c=11.001(15) ?, β=90.05(2)°), crystallized from the open air reaction of CoCl₂ and 2,4,6-tri(2-pyridyl)-1,3,5-triazine in the ionic liquid, N-butyl-N-methyl-pyrrolidinium bis(trifluoromethanesulfonyl)imide is reported. The structure consists of six coordinate cobalt in an octahedral geometry bonded to the tridentate tptz ligand and three chlorines. The non-coordinating pyridyl group in the tptz ligand is protonated (with the protonated nitrogen crystallographically disordered over two possible sites), providing overall charge neutrality for the complex.     

Crystal structures and vibrational spectra of racemic and chiral 4-phenyl-1,3-oxazolidine-2-thione

The crystal structures of (rac)- and (R)-4-phenyl-1,3-oxazolidine-2-thione (4-POT) have been determined by X-ray diffraction. The structure of (rac)-4-POT is monoclinic P2₁/n with a = 11.9096(9) Å, b = 5.9523(6) Å, c = 12.3563(8) Å, = 91.054(6)°, V = 875.8(1) ų, and Z = 4. The structure of (R)-4-POT is orthorhombic P2₁2₁2₁ with a = 7.7197(6) Å, b = 21.603(2) Å, c = 5.4613(9) Å, V = 910.8(2) ų, and Z = 4. (rac)-4-POT and (R)-4-POT crystals are shown to have different hydrogen-bonding patterns. In the racemic crystals, the enantiomeric (R)- and (S)-4-POT molecules are connected to form a cyclic dimer via the N–H S hydrogen bond of the cis thioamide moiety [N Sⁱ 3.438(2) Å, N–H Sⁱ 176(2)° symmetry code: (i) 1 – x, 1 – y, 1 – z]. In the chiral (R)-4-POT crystals, the N–H S intermolecular hydrogen bond forms a zigzag chain around the twofold screw axis [N Sⁱⁱ 3.347(3) Å, N–H Sⁱⁱ 161(3)° symmetry code: (ii) 1/2 + x, 1/2 – y, 2 – z]. Observed difference of 46°C in the melting points between the (rac)-4-POT and (R)-4-POT crystals is correlated with difference in the crystal packing. Vibrational spectra of (rac)- and (R)-4-POT crystals are discussed both in the solid state and in solution.     

Synthesis and crystal structure of 4-(p-methoxyphenyl)-3, 5-bis(4-pyridyl)-1,2,4-triazole

The 4-(p-methoxyphenyl)-3,5-bis(4-pyridyl)-1,2,4-triazole has been synthesized and its crystal structure has been determined by X-ray diffraction methods. It crystallizes in the monoclinic space group P2₁/n, with a = 12.5832(6) Å, b = 7.0512(5) Å, c = 18.4669(12) Å, = 96.826(1)°, and D_calc = 1.345 g cm^–1 for Z = 4. In the structure, two pyridyl rings, phenyl ring, and triazole ring do not share a common plane. The most favored orientation of the pyridyl rings in the crystal is that their planes are inclined toward opposite directions with respect to the triazole ring.     

Synthesis and X-ray structure of 3-(4-methyl phenyl)-2-(4-biphenyl)-1,3-thiazolidin-4-one

The title compound (C₂₂H₁₉NOS) was synthesized, characterized and structure was determined by X-ray diffraction method. It crystallizes in the monoclinic space group P2₁/c with cell parameters a = 22.181(2) Å, b = 6.0760(4) Å, c = 13.349(3) Å, = 95.615(3)^, and {Z = 4}. The final residual factor is 0.0625 for 1724 reflections with I > 2(I). 4-thiazolidinone ring moiety shows twisted conformation.     

Synthesis and crystal structure of Cu3(Bipy)2(L1)2(L2)2? 4H2O(Bipy = 2,2′-bipyridine, L1 =1-((2-sulfonateethylimino)methyl)-2-naphthol), L2 = 2-hydroxy-1-naphthaldehyde)

The title compound, Cu₃(Bipy)₂(L¹)₂(L²)₂⋅4H₂O, was synthesized in the methanol solution of Bipy and Cu(II) in the presence of 1-((2-sulfonate-ethylimino)-methyl)-2-naphthol (L¹), which was condensation compound of taurine and 2-hydroxy-1-naphthaldehyde. This complex crystallized in the space group P-1 with a = 9.825(2) ?, b = 12.626(2) ?, c = 14.342(3) ?, α = 90.29(1)^∘, β = 100.67(1)^∘, γ = 101.67(2)^∘, and Z = 2. In the trinuclear Cu(II) complex, there are two type Cu atoms which have square and square pyramid geometries, respectively. The Cu–N distances vary from 1.965(3) to 2.000(4) ?, while the Cu–O distances are between 1.896(3) and 2.337(4) ?.     

EPR spectra of (L-aspartate)di(2-pyridyl)aminezinc(II) hydrate substitutionally copper(II) doped complex

The [(L-aspartate)di(2-pyridyl)aminezinc(II)]hydrate doped with traces of copper was prepared. Electron paramagnetic resonance spectra of the polycrystalline sample were recorded at room temperature by using the X-band of the EPR spectrometer. The observedg factors for the complex areg _‖=2.258 andg _⊥=2.066. TheA _‖ value is 165.10⁻⁴ cm⁻¹. The crystal and molecular structure of the complex are also reported. The complex crystallizes in the monoclinic system; space groupP2₁ witha=7.2053(11),b=10.447(2),c=10.812(2) Å, β=108.489(14)° andZ=2. The structure can be described in the crystal lattice as polymeric chains.     

EPR spectra of (L-aspartate)di(2-pyridyl)aminezinc(II) hydrate substitutionally copper(II) doped complex

The [(L-aspartate)di(2-pyridyl)aminezinc(II)]hydrate doped with traces of copper was prepared. Electron paramagnetic resonance spectra of the polycrystalline sample were recorded at room temperature by using the X-band of the EPR spectrometer. The observedg factors for the complex areg _‖=2.258 andg _⊥=2.066. TheA _‖ value is 165.10⁻⁴ cm⁻¹. The crystal and molecular structure of the complex are also reported. The complex crystallizes in the monoclinic system; space groupP2₁ witha=7.2053(11),b=10.447(2),c=10.812(2) Å, β=108.489(14)° andZ=2. The structure can be described in the crystal lattice as polymeric chains.     

Crystal Structure of 1,7-Bis(4-chlorophenyl)-4-(1,3-dithiolan-2-ylidene)-1,6-heptadiene-3,5-dione

Abstract  The synthesis and crystal structure of 1,7-bis(4-chlorophenyl)-4-(1,3-dithiolan-2-ylidene)-1,6-heptadiene-3,5-dione is described. This compound is a curcuminoid analogue, configurationally symmetric about the C4–C5 atoms and also retains the two fold axis in the crystal phase. This compound crystallizes in the space group C2/c with unit cell parameters a = 19.203(1) ?, b = 13.147(1) ?, c = 8.801(1) ?, β = 112.99(1)°, with half a molecule in the asymmetric unit. The ketenedithioacetal functionality present between the carbonyl groups prevents the possibility of keto-enol tautomerization in this compound. The push-pull nature of the ketenedithioacetal functionality organizes the cinnamoyl groups parallel to each other. Index Abstract  The details regarding synthesis and crystal structure of the title compound which is a curcuminoid analogue is reported in this paper.      

Methyl 4-((E)-2-{3-[(3-{ (E)-2-[4-(methoxycarbonyl)phenyl]- 1-diazenyl}-5,5-dimethylhexahydro-1-pyrimidinyl)methyl]-5,5-dimethylhexahydro-1-pyrimidinyl-1-diazenyl) benzoate. X-ray crystal structure

Methyl 4-((E)-2-{3-[(3-{(E)-2-[4-(methoxycarbonyl)phenyl]-1-diazenyl}-5, 5-dimethyl hexahydro-1-pyrimidinyl)methyl]-5, 5- dimethylhexahydro-1- pyrimidinyl}-1- diazenyl) benzoate (1) has been synthesized by reaction of a mixture of formaldehyde and 2,2-dimethyl-1,3-propanediamine with p-methoxycarbonylbenzenediazonium chloride. The crystal structure of 1 has been determined by single crystal X-ray diffraction analysis. The crystals of 1 displayed problems of disorder; the asymmetric unit is built up by two independent molecules, which display disorder within a methoxycarbonyl group. The two independent molecules in the asymmetric unit are very similar, differing only slightly about the mutual orientation of the aryltriazenyl groups. With respect to the N–C–N bridge between the hexahydropyrimidinyl rings, the two equivalent fragments containing the triazene moieties are in a cis orientation. The N–N single bonds, in the range 1.319(4)–1.348(4) Å, and the N=N double bonds, in the range 1.255(5)–1.275(4) Å, indicate significant conjugations within the triazene moieties. All the hexahydropyrimidine six-membered rings adopt a chair conformation as shown by their puckering parameters. The crystal packing is determined only by simple van der Waals interactions. The crystal structure of 1 is compared with the previously reported structure of the unbranched hexahydropyrimidine analogue 2. Crystal data: 1 C29H40N8O4, triclinic, space group P-1, a = 13.9652(2), b = 14.2908(3), c = 16.6129(4) Å, = 97.279(1), = 90.872(1), = 107.385(1), V = 3133.6(1) ų, for Z = 4.     

Synthesis and crystal structure characterization of (E)-2,2,2-Trifluoro-N-[2-(2-nitrovinyl)phenyl]acetamide

The title compound, (E)-2,2,2-trifluoro-N-[2-(2-nitrovinyl)phenyl]acetamide, was synthesized and characterized by ¹H and ¹³C NMR and HRMS spectroscopy. Its molecular configuration was investigated by X-ray crystallography. The crystal structure analysis revealed that the structure exhibits intermolecular hydrogen bonds of the type N–H…O and intermolecular hydrogen bonds of the type N–H…F, and molecules are linked by weak C–H…O contacts. Furthermore, the two oxygen atoms of nitro group are disordered over two positions, respectively, with site occupancy factors of 0.8:0.2 and 0.6:0.4. Three fluorine atoms are also disordered over two positions, respectively, one fluorine atom with site occupancy factors of 0.6:0.4 and the other two fluorine atoms with site occupancy factors of 0.5:0.5.     

X-ray structure analysis of 1-(4-bromophenyl)-3-(4-chlorophenyl)-prop-2-en-1-one

The title compound crystallizes in the monoclinic space group P2₁/c with unit cell parameters a = 15.6239(15) ?, b = 14.0537(14) ?, c = 5.8396(5) ?, β = 92.666(3)°, V = 1280.8 (2) ?³, and Z = 4. The final reliability index is 0.0538 for 2921 observed reflections. Two phenyl rings of the title molecule are not coplanar, with a dihedral angle of 46.3(0)°. The molecular planarity of this substituted chalcone is strongly affected by the 4′-bromo group. The crystal cohesion is accentuated by π···π, C–H···Br interactions and R₃ ¹ (11) hydrogen bond.     

X-ray Structures of Pharmacologically Active 2-(3,5-Dimethyl-pyrazol-1-yl)-methylacetanilides

Abstract X-ray structures of three pharmacologically active lidocaine analogs, containing a common, substituted pyrazole moiety as the basic residue and variously substituted phenyl rings as the hydrophobic residue, have been determined. This isomeric series comprises 2-(3,5-dimethyl-pyrazol-1-yl)-2′-methylacetanilide (1), 2-(3,5-dimethyl-pyrazol-1-yl)-3′-methylacetanilide monohydrate (2), and 2-(3,5-dimethyl-pyrazol-1-yl)-4′-methylacetanilide (3). Crystal data are 1: space group P2 ₁ /c with a = 4.7617(2), b = 11.5638(4), c = 23.603(1) ?, β = 90.736(2)°, Z = 4; 2: P2 ₁ /c with a = 4.7260(1), b = 13.7001(4), c = 21.7006(6) ?, β = 93.425(1)°, Z = 4; 3: P2 ₁ /n with a = 6.4103(3), b = 24.584(1), c = 8.4449(4) ?, β = 100.273(3)°, Z = 4. In 1–3, the amide bond is trans-planar but the basic and hydrophobic residues adopt different orientations relative to this plane. Hydrogen bonding in 1 and 3 is based on C(4) linear arrays whereas in the monohydrate 2, the presence of water gives rise to R ₄ ⁴ (16) ring motifs. A summary of the local anesthetic and anti-arrhythmic properties of 1–3 is provided. Graphical abstract X-ray Structures of Pharmacologically Active 2-(3,5-Dimethyl-pyrazol-1-yl)-methylacetanilides Christina Zalaru, Mino R. Caira, Mircea Iovu, and Elena Cristea The title compounds are lidocaine analogs that display local anesthetic and anti-arrhythmic activities. X-ray analyses revealed a range of solid-state conformations among these isomeric compounds as well as variation in hydrogen bonding schemes, namely C(4) (R = o-, p-CH3) and R44(16) (R = m-CH3, monohydrate crystal). 1,1-Os3(CO)9(μ-CO)(phen)     

Structural study on a new Cs2S2(SO4)3 crystal

A new type of dicesium disulfur trisulfate, Cs₂S₂(SO₄)₃, crystal has been crystallized. Differential scanning calorimetry (DSC) and X‐ray diffraction measurements have been performed on this compound. The crystal does not reveal any structural phase transition in the temperature range from 120 to 920 K. The compound belongs to a cubic system with space group P2₁3 at room temperature. It is found that both Cs and S atoms located on special positions are 93% occupied and 7% in exchange with each other. (© 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)     

Synthesis and crystal structure of 2-anilino-6<Emphasis Type="Italic">H</Emphasis>-5-(1-phenyl-3-methyl-5-pyrazolone-4-ylene)-1,3,4-thiadiazine

A novel pyrazolone derivative 2-anilino-6H-5-(1-phenyl-3-methyl-5-pyrazolone-4-ylene)-1,3,4-thiadiazine (PMCP-PTSC) containing NNS hexa-atomic heterocycle has been obtained and characterized by means of single crystal X-ray diffraction, IR and ¹H NMR spectroscopies. It is interesting that when grown from two different solvents, two different crystalline structures are formed. The monoclinic crystal A belongs to a P2₁/c space group. The unit cell parameters are a = 16.414(4) Å, b = 12.530(3) Å, c = 8.432(1) Å, = 91.75(2) Å, and Z = 4. The triclinic crystal B belongs to a P space group. The unit cell parameters are a = 11.386(2) Å, b = 12.326(2) Å, c = 12.411(3) Å, = 83.07(1)°, = 87.76(2)°, = 86.52(2)°, and Z = 4. The structure analyses show the title compound is the keto-form. Dimers in crystal packing of A and supramolecular one-dimensional (B) concatenate structures were assembled by the intermolecular hydrogen bonds.